Winald Gerritsen is a professor of Tumour Immunotherapy at Radboud University Medical Centre Nijmegen. Professor Gerritsen also serves as an Adjunct Professor at John Hopkins University, and is a member of the Royal Holland Society of Sciences and Humanities.
Professor Gerritsen has previously served as the Chairman of the Commission on Clinical Research (Dutch Cancer Society) and the Commission on Biotherapy (National Translational Cancer Research Network). Professor Gerritsen is a member of the scientific advisory board for Aglaia Biomedical Ventures and ORCA therapeutics.
Professor Gerritsen has particular experience in translational research, with a special interest in tumour-immunology and prostate cancer. He has been involved in several clinical studies involving adenoviral, adeno-associated viral and retroviral gene therapies.